-
Location
-
780 Third Avenue, 37 Th Floor, New York, NY
-
Summary
-
The estimated net worth of James E. Flynn is at least $2.28B dollars as of May 15, 2025. James E. Flynn is the Director, * Director by deputization, 10%+ Owner of Nuvalent, Inc. and owns shares of Nuvalent, Inc. (NUVL) stock worth about $1.76B. James E. Flynn is the 10%+ Owner of ARS Pharmaceuticals, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $187M. James E. Flynn is the *Possible Member of 10% Group, 10%+ Owner of AdaptHealth Corp. and owns shares of AdaptHealth Corp. (AHCO) stock worth about $142M. James E. Flynn is the * Possible Member of 10% Group, 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $91M. James E. Flynn is the Director, Director by Deputization, 10%+ Owner of CareMax, Inc. and owns shares of CareMax, Inc. stock worth about $54.7M. James E. Flynn is the Possible Members of 10% Group, 10%+ Owner of Bicara Therapeutics Inc. and owns shares of Bicara Therapeutics Inc. (BCAX) stock worth about $23.8M. James E. Flynn is the Director, Director by deputization of Acutus Medical, Inc. and owns shares of Acutus Medical, Inc. (AFIB) stock worth about $4.16M. James E. Flynn is the Possible Member of 10% Group, 10%+ Owner of PepGen Inc. and owns shares of PepGen Inc. (PEPG) stock worth about $3.97M. James E. Flynn is the *Possible Member of 10% Group, 10%+ Owner of Singular Genomics Systems, Inc. and owns shares of Singular Genomics Systems, Inc. stock worth about $3.89M. James E. Flynn is the Possible Members of 10% Group, 10%+ Owner of Fractyl Health, Inc. and owns shares of FRACTYL HEALTH, INC. (GUTS) stock worth about $2.42M. James E. Flynn is the Director, *Director by Deputization of BiomX Inc. and owns shares of BiomX Inc. (PHGE) stock worth about $2.32M. James E. Flynn is the Possible Member of 10% Group, 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $1.9M. James E. Flynn is the Possible Members of 10% Group, 10%+ Owner of Oncology Institute, Inc. and owns shares of Oncology Institute, Inc. (TOI) stock worth about $448K.
-
Signature
-
/s/ Jonathan Isler, Attorney-in-Fact